Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003892
Filing Date
2021-11-10
Accepted
2021-11-10 07:02:55
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dbtx-20210930.htm   iXBRL 10-Q 3726089
2 EX-31.1 dbtx-ex31_1.htm EX-31.1 16628
3 EX-31.2 dbtx-ex31_2.htm EX-31.2 16668
4 EX-32.1 dbtx-ex32_1.htm EX-32.1 10214
5 EX-32.2 dbtx-ex32_2.htm EX-32.2 10268
  Complete submission text file 0000950170-21-003892.txt   10780310

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dbtx-20210930_def.xml EX-101.DEF 188889
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dbtx-20210930.xsd EX-101.SCH 51699
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dbtx-20210930_pre.xml EX-101.PRE 323471
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dbtx-20210930_lab.xml EX-101.LAB 407452
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dbtx-20210930_cal.xml EX-101.CAL 41409
11 EXTRACTED XBRL INSTANCE DOCUMENT dbtx-20210930_htm.xml XML 2031431
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40030 | Film No.: 211394348
SIC: 2834 Pharmaceutical Preparations